Dr Reddy's eyes brand buys, biosimilars in Russian scale-up
This article was originally published in Scrip
Executive Summary
Dr Reddy's Laboratories has identified a clutch of opportunities, including brand acquisitions and a potential play in the biosimilars segment, to drive its next wave of growth in the Russian market.